These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 13994391)

  • 1. [Constitutional anf nonhematological changes in thalassemia].
    TRUNIGER B; SCHMID M
    Schweiz Med Wochenschr; 1962 Nov; 92():1388-91. PubMed ID: 13994391
    [No Abstract]   [Full Text] [Related]  

  • 2. Bone changes in thalassaemia trait; an x-ray appraisal of 55 cases.
    SFIKAKIS P; STAMATOYANNOPOULOS G
    Acta Haematol; 1963 Apr; 29():197-203. PubMed ID: 13992754
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of bone lesions in thalassemia].
    SARROUY C; GILLOT F; CABANNES R; SENDRA L; CLAUSSE J; BOINEAU N
    Pediatrie; 1957; 12(2):209-13. PubMed ID: 13431363
    [No Abstract]   [Full Text] [Related]  

  • 4. [The international nomenclature of so-called "constitutional bone diseases"].
    Nigro N
    Minerva Pediatr; 1993 Mar; 45(3):73-4. PubMed ID: 8341229
    [No Abstract]   [Full Text] [Related]  

  • 5. [Notes on the bones found in the excavations of the cemeteries of Spina; confirmations of the Greek racial origin of thalassemia].
    BENASSI E; TOTI A
    Rass Clin Ter; 1958; 57(1):16-28. PubMed ID: 13554877
    [No Abstract]   [Full Text] [Related]  

  • 6. [Observations on bone found in excavations of the necropolis of Spina; confirmation of the Greek racial origin of thalassemia].
    BENASSI E; TOTI A
    Minerva Fisioter Radiobiol; 1957; 2(5):215-23. PubMed ID: 13516662
    [No Abstract]   [Full Text] [Related]  

  • 7. Markers of bone metabolism in eugonadal female patients with beta-thalassemia major.
    Angelopoulos NG; Goula A; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Konstandelou E; Tolis G
    Pediatr Hematol Oncol; 2007; 24(7):481-91. PubMed ID: 17786784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [hTERT gene expression in children with beta-thalassemia major].
    Li XH; Tang J; Guo WJ; Qu Y; Yu F; Wang XY; Wang FL; Mu DZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):449-52. PubMed ID: 19558808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone and maxillofacial abnormalities in thalassemia: a review of the literature.
    Di Matteo R; Liuzza F; Manicone PF; Raffaelli L; Berardi D; Perfetti G; Maccauro G
    J Biol Regul Homeost Agents; 2008; 22(4):211-6. PubMed ID: 19036222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The "lively" cytokines network in beta-Thalassemia Major-related osteoporosis.
    Morabito N; Russo GT; Gaudio A; Lasco A; Catalano A; Morini E; Franchina F; Maisano D; La Rosa M; Plota M; Crifò A; Meo A; Frisina N
    Bone; 2007 Jun; 40(6):1588-94. PubMed ID: 17412659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P; Arumugam PI; Yee JK; Puthenveetil G
    Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of human telomerase reverse transcriptase in bone marrow CD34+ cells from patients with beta-thalassemia major.
    Li X; Qu Y; Mao M; Yu F; Li Q; Hua Y; Mu D
    Transfusion; 2008 Aug; 48(8):1627-33. PubMed ID: 18466174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pubertal evaluation of adolescent boys with beta-thalassemia major and delayed puberty.
    Al-Rimawi HS; Jallad MF; Amarin ZO; Al Sakaan R
    Fertil Steril; 2006 Oct; 86(4):886-90. PubMed ID: 17027358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel transgenic mouse model produced from lentiviral germline integration for the study of beta-thalassemia gene therapy.
    Li W; Xie S; Guo X; Gong X; Wang S; Lin D; Zhang J; Ren Z; Huang S; Zeng F; Zeng Y
    Haematologica; 2008 Mar; 93(3):356-62. PubMed ID: 18268280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
    Perifanis V; Vyzantiadis T; Tziomalos K; Vakalopoulou S; Garipidou V; Athanassiou-Metaxa M; Harsoulis F
    Ann Hematol; 2007 Jan; 86(1):23-30. PubMed ID: 17013645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoglobin D/beta-thalassemia and beta-thalassemia major in a Saudi family.
    Owaidah TM; Al-Saleh MM; Al-Hellani AM
    Saudi Med J; 2005 Apr; 26(4):674-7. PubMed ID: 15900384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [International nomenclature of the "constitutional diseases of bones"].
    Nigro N
    Minerva Pediatr; 1997 Sep; 49(9):451-2. PubMed ID: 9471550
    [No Abstract]   [Full Text] [Related]  

  • 18. Diamond-Blackfan anemia associated with beta-thalassemia trait.
    Tavil B; Cetin M; Kuşkonmaz B; Gümrük F
    Am J Hematol; 2006 Mar; 81(3):214-5. PubMed ID: 16493623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exogenous iron increases hemoglobin in beta-thalassemic mice.
    Ginzburg YZ; Rybicki AC; Suzuka SM; Hall CB; Breuer W; Cabantchik ZI; Bouhassira EE; Fabry ME; Nagel RL
    Exp Hematol; 2009 Feb; 37(2):172-83. PubMed ID: 19059700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A deletion of 11 bp (CD 131-134) in exon 3 of the beta-globin gene produces the phenotype of inclusion body beta-thalassemia.
    Ropero P; Villegas A; Martínez M; Ataulfo González Fernández F; Benavente C; Mateo M
    Ann Hematol; 2005 Sep; 84(9):584-7. PubMed ID: 15977037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.